EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Clinical course of Graves’ orbitopathy in children with newly diagnosed hyperthyroidism: a prospective observational study

Derya Tepe iD, Duygu Deligozoglu iD, Ceyda Baskan iD, Refika Gören iD, Pınar Kocaay iD, Fatih Gürbüz iD, Mehmet Boyraz iD

Journal of Pediatric Endocrinology and Metabolism · 24.07.2026 · 39 (7) · 701-710

DOI: 10.1515/jpem-2026-0095 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Pediatric Endocrinology and Metabolism, online erschienen am 20.05.2026. Verfasst von Derya Tepe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology, Ankara Bilkent City Hospital, Ankara, Türkiye. Hauptthemen laut MEDLINE: Graves Ophthalmopathy, Hyperthyroidism. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Although Graves’ orbitopathy (GO) in childhood is generally considered milder than in adults, data regarding its clinical course and relationship with thyroid autoimmunity remain limited. This study aimed to evaluate the frequency and clinical characteristics of GO in pediatric patients with newly diagnosed hyperthyroidism and to assess short-term changes in ocular findings during follow-up.

Methods

In this prospective observational study, 24 children with hyperthyroidism were enrolled. All ophthalmologic examinations were performed by the same ophthalmologist. Ocular findings were assessed according to the 2021 EUGOGO criteria, and disease activity was determined using the Clinical Activity Score (CAS). Thyroid function tests and autoantibodies, including anti-thyroid peroxidase antibody, thyrotropin receptor antibody, and thyroid-stimulating immunoglobulin, were evaluated at baseline and at 6 months. Associations between clinical, biochemical, and ophthalmologic parameters were analyzed statistically.

Results

The mean age was 14.1 ± 3.4 years, and 75 % of patients were female. At baseline, 83.3 % had mild GO and 16.7 % had moderate-to-severe disease. CAS values were

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graves OphthalmopathyHyperthyroidismHumansFemaleMaleProspective StudiesAdolescentChildFollow-Up StudiesAutoantibodiesPrognosisThyroid Function Tests

Stichwörter der Autor:innen

EUGOGOGraves’ diseaseGraves’ orbitopathyclinical activity scorepediatric hyperthyroidismthyrotropin receptor antibody

Substanzen

Autoantibodies

Autor:innen und Institutionen

  • Department of Pediatric Endocrinology, Ankara Bilkent City Hospital, Ankara, Türkiye.
  • Department of Ophthalmology, Ankara Bilkent City Hospital, Ankara, Türkiye.
  • Department of Pediatric Endocrinology, Yıldırım Beyazıt University, Ankara, Türkiye.

ORCID-Profile: Derya Tepe, Duygu Deligozoglu, Ceyda Baskan, Refika Gören, Pınar Kocaay, Fatih Gürbüz, Mehmet Boyraz

Zitieren

APA

Tepe, D., Deligozoglu, D., Baskan, C., Gören, R., Kocaay, P., Gürbüz, F., & Boyraz, M. (2026). Clinical course of Graves’ orbitopathy in children with newly diagnosed hyperthyroidism: a prospective observational study. Journal of Pediatric Endocrinology and Metabolism, 39(7), 701-710. https://doi.org/10.1515/jpem-2026-0095

Vancouver

Tepe D, Deligozoglu D, Baskan C, Gören R, Kocaay P, Gürbüz F, et al. Clinical course of Graves’ orbitopathy in children with newly diagnosed hyperthyroidism: a prospective observational study. Journal of Pediatric Endocrinology and Metabolism. 2026;39(7):701-710. doi:10.1515/jpem-2026-0095

BibTeX
@article{Tepe2026,
  author = {Tepe, Derya and Deligozoglu, Duygu and Baskan, Ceyda and Gören, Refika and Kocaay, Pınar and Gürbüz, Fatih and Boyraz, Mehmet},
  title = {Clinical course of Graves’ orbitopathy in children with newly diagnosed hyperthyroidism: a prospective observational study},
  journal = {Journal of Pediatric Endocrinology and Metabolism},
  year = {2026},
  volume = {39},
  number = {7},
  pages = {701--710},
  doi = {10.1515/jpem-2026-0095}
}
Kostenlos starten →